Waters' Q4 Revenues Flat; High-end Mass Spec Business Improving | GenomeWeb

NEW YORK (GenomeWeb News) – Waters today said that fourth-quarter revenues were essentially flat year over year as the firm missed analyst estimates on the top line but beat it on the bottom line.

For the three months ended Dec. 31, 2012 Waters posted $521.8 million in revenues compared to $521.4 million a year ago, missing the consensus Wall Street estimate of $522.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions.

Ancestry.com is eyeing an expansion into genomic risk assessments, the Verge reports.